Daewoong Pharmaceutical’s’Hoy Star Tablet’ approved for Phase 3 clinical trial… Development of the first oral drug to prevent coronavirus

Daewoong Pharmaceutical (CEO Seung-ho Jeon) announced on the 25th that it had received approval from the Ministry of Food and Drug Safety for a phase 3 clinical trial for preventing COVID-19 of’Hoy Star Tablet (ingredient name camostat mesylate)’. This clinical trial is a large-scale phase 3 clinical trial that confirms the effects of Hoystar tablets […]